Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of <scp>PD</scp>‐1 Inhibition as Potential Treatment Option
ABSTRACT Background Invasive mould infections (IMI) cause substantial morbidity and mortality in populations at risk. Novel treatment approaches are urgently needed. Targeting immune checkpoints may reverse hyporesponsiveness of the innate and adaptive immune systems. Methods In this prospective, ob...
Wedi'i Gadw mewn:
Prif Awduron: | Sibylle C. Mellinghoff, Martin Thelen, Michael von Bergwelt‐Baildon, Hans Schlößer, Oliver A. Cornely, Rosanne Sprute, Jannik Stemler, Leonie Mayer, Leonie M. Weskamm, Monika Friedrich, My Linh Ly, Christine Dahlke, Marylyn M. Addo |
---|---|
Fformat: | Artigo |
Iaith: | Saesneg |
Cyhoeddwyd: |
2025
|
Mynediad Ar-lein: | https://doi.org/10.1111/myc.70044 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
gan: Mellinghoff, Sibylle C., et al.
Cyhoeddwyd: (2021) -
Antifungal prophylaxis and pre-emptive therapy: When and how?
gan: Rosanne Sprute, et al.
Cyhoeddwyd: (2023) -
Correlates of Vaccine-Induced Protection against SARS-CoV-2
gan: Koch, Till, et al.
Cyhoeddwyd: (2021) -
Correlates of Vaccine-Induced Protection against SARS-CoV-2
gan: Till Koch, et al.
Cyhoeddwyd: (2021) -
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
gan: Weskamm, Leonie M., et al.
Cyhoeddwyd: (2022)